March 6, 2012 — In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) t ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
February 24, 2012 – The U.S. Food and Drug Administration (FDA) this week granted the first coronary stent indication ...
February 20, 2012 — Medtronic announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity drug ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
February 6, 2012 — InspireMD Inc. announced positive clinical results for its MGuard stent from a controlled randomized ...
February 6, 2012 — A medical technology company commercializing the world's first and only self-apposing stent to treat ...
February 1, 2012 — Boston Scientific announced the first patient use and European market launch of the Promus Element ...
January 23, 2012 – Boston Scientific Corp. said the U.S. District Court for the District of New Jersey has found all the ...
January 18, 2012 — Boston Scientific reported nine-month clinical endpoint data from its ORION trial, demonstrating ...
January 9, 2012 – A registry that includes every patient in Sweden having percutaneous coronary intervention (PCI) found ...
January 4, 2012 – ECRI, an independent nonprofit that researches the best approaches to improving patient care, listed ...
December 22, 2011 – Abbott today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in Europe ...
December 20, 2011 – Boston Scientific reported positive long-term data from the PERSEUS clinical program, which ...
December 19, 2011 – The Maryland Chapter of the American College of Cardiology (ACC) and the Society for Cardiovascular ...
December 12, 2011 - Boston Scientific recently announced U.S. Food and Drug Administration (FDA) approval for the Promus ...
December 9, 2011 — Abbott announced Thursday the initiation of ABSORB II, the first randomized, controlled, multi-center ...